Ameliorative role of Polyscias fruticosa leaf extract in aluminum chloride-induced neurotoxicity flies possibly mediated by N-methyl-D-aspartate receptor antagonistic and anticholinesterase active compounds
- PMID: 40646316
- DOI: 10.1007/s11418-025-01928-0
Ameliorative role of Polyscias fruticosa leaf extract in aluminum chloride-induced neurotoxicity flies possibly mediated by N-methyl-D-aspartate receptor antagonistic and anticholinesterase active compounds
Abstract
Polyscias fruticosa leaves have been used in traditional medicine to aid in the therapy of brain and nerve-related disorders, including dementia. However, the evidences for the effects and mechanisms of P. fruticosa leaf extract (PFLE) and its constituents in improving dementia remain unclear. This study aims to evaluate the ameliorative effect of PFLE in aluminum chloride-induced neurotoxicity Drosophila melanogaster model. Simultaneously, the dementia-improving mechanisms of PFLE's compounds were explored by computational pharmacological analysis. Results showed that D. melanogaster exposed to 1.0, 2.0, and 4.0 mg/mL PFLE or 0.1 mg/mL donepezil hydrochloride had significant improvements in lifespan, memory, motor behavior, and oxidative stress markers, including decreased malondialdehyde level and increased glutathione level in flies' homogenates. Also, PFLE had acetylcholinesterase inhibitory ability with an IC50 value of 266.10 µg/mL. Applying the UHPLC-Q-TOF-MS/MS technique, 36 compounds were identified in the PFLE. Among these, 25 compounds, including acid amines, flavonoids, saponins, choline, piperine, and vitamin B1, have been demonstrated potential for supporting the treatment of Alzheimer's disease (AD). Interestingly, molecular docking study indicated that many of the compounds are agents of prominent targets in dementia treatment including N-methyl-D-aspartate (NMDA) receptor and cholinesterase, in which polyscioside A-E are the main components of the PFLE that may be responsible for the NMDA receptor antagonistic and anticholinesterase activities. These compounds have favorable physiochemical properties and drug-likeliness. This study suggested the potential of the PFLE and its compounds in the prophylactic and treatment of neurodegenerative pathologies, including AD, and laid the foundation for further studies.
Keywords: N-Methyl-d-aspartate (NMDA) receptor antagonists; Polyscias fruticosa leaves; Aluminum chloride (AlCl3); Alzheimer’s disease; Anti-cholinesterase; Neurotoxicity.
© 2025. The Author(s) under exclusive licence to The Japanese Society of Pharmacognosy.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no competing interests.
Similar articles
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2. Cochrane Database Syst Rev. 2021. PMID: 33704781 Free PMC article.
-
Galantamine for Alzheimer's disease.Cochrane Database Syst Rev. 2002;(3):CD001747. doi: 10.1002/14651858.CD001747. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001747. doi: 10.1002/14651858.CD001747.pub2. PMID: 12137632 Updated.
-
Galantamine for Alzheimer's disease.Cochrane Database Syst Rev. 2001;(4):CD001747. doi: 10.1002/14651858.CD001747. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747. doi: 10.1002/14651858.CD001747. PMID: 11687119 Updated.
-
Cholinesterase inhibitors for Alzheimer's disease.Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005593. doi: 10.1002/14651858.CD005593. Cochrane Database Syst Rev. 2006. PMID: 16437532 Free PMC article.
References
-
- Dordevic D, Buchtova H, Jancikova S, Macharackova B, Jarosova M, Vitez T, Kushkevych I (2019) Aluminum contamination of food during culinary preparation: case study with aluminum foil and consumers’ preferences. Food Sci Nutr 7:3349–3360. https://doi.org/10.1002/fsn3.1204 - DOI - PubMed - PMC
-
- Skalny AV, Aschner M, Jiang Y, Gluhcheva YG, Tizabi Y, Lobinski R, Tinkov AA (2021) Chapter one—molecular mechanisms of aluminum neurotoxicity: update on adverse effects and therapeutic strategies. In: Aschner M, Costa LG (eds) Advances in neurotoxicology. Academic Press, pp 1–34
-
- Pamphlett R, Buckland ME, Bishop DP (2023) Potentially toxic elements in the brains of people with multiple sclerosis. Sci Rep 13:655. https://doi.org/10.1038/s41598-022-27169-9 - DOI - PubMed - PMC
-
- Mold M, Umar D, King A, Exley C (2018) Aluminium in brain tissue in autism. J Trace Elem Med Biol 46:76–82. https://doi.org/10.1016/j.jtemb.2017.11.012 - DOI - PubMed
-
- Kumar A, Sidhu J, Lui F, Tsao JW (2024) Alzheimer disease. StatPearls Publishing, Treasure Island
LinkOut - more resources
Full Text Sources